Business Wire

FDA Approves Genzyme’s Synvisc-One for Osteoarthritis of the Knee

Important Therapy Provides Six Months Pain Relief with Single Injection CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration ...
FierceBiotech

FDA Advisory Committee Unanimously Recommends Approval of Genzyme's Synvisc-One

Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
FierceBiotech

PRESS RELEASE: Genzyme Corporation Receives FDA Response Letter on Synvisc-One(TM) Approval in U.S. to be Delayed

CAMBRIDGE, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that it has received a letter from the U.S. Food and Drug Administration requesting ...
Reuters

U.S. advisers back Genzyme therapy for knee pain

GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel has unanimously backed a new version of a Genzyme Corp injection to relieve knee pain from osteoarthritis. The panel of experts voted 5-0 on ...
BioWorld

FDA Advisers Back New Version of Genzyme's Knee-Pain Drug

A federal panel of advisers Tuesday voted unanimously in favor of approval of Genzyme Corp.'s Synvisc-One, an investigational injectable product intended to relieve pain associated with osteoarthritis ...
Reuters

Genzyme wins OKs for Myozyme plant; Synvisc-One

BOSTON, Feb 26 (Reuters) - Genzyme Corp said on Thursday it has won European approval to make its drug Myozyme at a 4,000-liter manufacturing facility, expanding supply for patients with the rare ...